Zonisamide Capsule
Product Images NDC 59651-378

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 59651-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Proportion Of Patients Achieving Differing Levels (Zonisamide Fig1)

A cumulative distribution plot comparing the percentage reduction in all partial seizure rates between treatment arms of Zonisamide and placebo in patients. The x-axis represents the percentage of patients, and the y-axis shows the percent change in seizure rate, ranging from negative to positive values, with direction indicators for improvement and worsening.*

FDA Label Image

Package Label Principal Display Panel (25 mg (30 Tablet Bottle))

Zonisamide Capsules USP 25 mg carton label for 30 capsules by Aurobindo Pharma Limited. The label includes dosage strength (25 mg), storage instructions, distributor information for Aurobindo Pharma USA, and a barcode. It states the product is Rx only and each capsule contains 25 mg Zonisamide USP.*

FDA Label Image

Package Label Principal Display Panel (50 mg (30 Tablet Bottle))

Zonisamide Capsules USP 50 mg packaging label from Aurobindo Pharma Limited. The label states the product contains 30 capsules with each capsule containing 50 mg of zonisamide. It includes storage instructions and distributor information for Aurobindo Pharma USA, Inc. The label also features an NDC number and barcode.*

FDA Label Image

Package Label Principal Display Panel (100 mg (30 Tablet Bottle))

Label for Zonisamide Capsules USP 100 mg, a drug for further processing. The label indicates a package containing 30 capsules, distributed by Aurobindo Pharma USA, Inc., made in India, with storage instructions and a barcode. It notes the dosage form as capsules and includes a coding area for printing.*

FDA Label Image

Chemical Structure (Zonisamide Str)

Chemical structure of Zonisamide, depicted as a benzisoxazole ring with a methylsulfonamide side group. This diagram shows the molecular arrangement of the active ingredient Zonisamide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.